1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Mayne Pharma Group Limited
  6. News
  7. Summary
    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about MAYNE PHARMA GROUP LIMITED
05/09Mayne pharma announced as recipient of $4.8m federal government grant
AQ
05/09Mayne Pharma Group Secures $3.4 Million Manufacturing Grant
MT
03/22Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT
AQ
03/21MAYNE PHARMA : 22/03/2022 Non Executive Director Appointment
PU
03/21Ann Custin Accepts to Join the Board and Audit and Risk Committee of Mayne Pharma Group..
CI
03/20MAYNE PHARMA GROUP LIMITED(ASX : MYX) added to S&P/ASX Emerging Companies Index
CI
02/28Mayne pharma reports 1hfy22 results
AQ
02/25Mayne Pharma Group Narrows Loss in Six Monts to December 2021
MT
02/24TRANSCRIPT : Mayne Pharma Group Limited, H1 2022 Earnings Call, Feb 24, 2022
CI
02/24MAYNE PHARMA : 2022 Half Year Investor Presentation
PU
02/24MAYNE PHARMA : 25/02/2022 Mayne Pharma 2022 Half Year Results Media Release
PU
02/24Mayne Pharma Group Limited Reports Earnings Results for the Half Year Ended December 31..
CI
02/11Mayne pharma expands us dermatology portfolio
AQ
02/10MAYNE PHARMA : 10/02/2022 Mayne Pharma expands US dermatology portfolio
PU
02/10Mayne Pharma Expands U.S Dermatology Portfolio
CI
More most relevant news
All news about MAYNE PHARMA GROUP LIMITED
05/09Mayne pharma announced as recipient of $4.8m federal government grant
AQ
05/09Mayne Pharma Group Secures $3.4 Million Manufacturing Grant
MT
03/22Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT
AQ
03/21MAYNE PHARMA : 22/03/2022 Non Executive Director Appointment
PU
03/21Ann Custin Accepts to Join the Board and Audit and Risk Committee of Mayne Pharma Group..
CI
03/20MAYNE PHARMA GROUP LIMITED(ASX : MYX) added to S&P/ASX Emerging Companies Index
CI
02/28Mayne pharma reports 1hfy22 results
AQ
02/25Mayne Pharma Group Narrows Loss in Six Monts to December 2021
MT
02/24TRANSCRIPT : Mayne Pharma Group Limited, H1 2022 Earnings Call, Feb 24, 2022
CI
02/24MAYNE PHARMA : 2022 Half Year Investor Presentation
PU
More news
News in other languages on MAYNE PHARMA GROUP LIMITED
03/21Ann Custin accepte de rejoindre le conseil d'administration et le comité d'audit et de ..
02/25Le groupe Mayne Pharma réduit ses pertes en six mois jusqu'en décembre 2021
02/25Degroof Petercam verlaagt koersdoel Mithra licht
02/24Mayne Pharma Group Limited annonce ses résultats pour le semestre clos le 31 décembre 2..
02/10Mayne Pharma élargit son portefeuille de produits dermatologiques aux États-Unis
02/10Mayne Pharma Group Limited conclut un accord de licence et d'approvisionnement
01/16Mayne Pharma Group Limited annonce des changements de direction
01/11Mayne Pharma commence la distribution aux États-Unis de la pommade générique contre la ..
01/11Mayne Pharma Group Limited commence la distribution de la pommade Tacrolimus
01/04Alembic Pharmaceuticals obtient le feu vert final de la FDA pour les comprimés d'hyclat..
More news
Press releases
05/09Mayne pharma announced as recipient of $4.8m federal government grant
AQ
03/22Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT
AQ
03/21MAYNE PHARMA : 22/03/2022 Non Executive Director Appointment
PU
02/28Mayne pharma reports 1hfy22 results
AQ
02/24MAYNE PHARMA : 2022 Half Year Investor Presentation
PU
More press releases
Upcoming event on MAYNE PHARMA GROUP LIMITED